Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1336

1.

Influence of the Body Mass Index and its Effect on Tumor Characteristics and Survival among a Population with Access to Surgical Management of Upper Tract Urothelial Carcinoma.

Inamoto T, Sassa N, Hattori R, Ibuki N, Komura K, Minami K, Takai T, Uchimoto T, Saito K, Tanda N, Tsujino T, Sano T, Kato M, Tsuzuki T, Gotoh M, Azuma H.

Curr Urol. 2019 Jul;12(4):201-209. doi: 10.1159/000499305. Epub 2019 Jul 20.

2.

Basophil-expressing genes related with the efficacy of sublingual immunotherapy.

Gotoh M, Kaminuma O, Nakaya A, Saeki M, Nishimura T, Kitamura N, Hiroi T, Kimihiro Okubo A.

J Nippon Med Sch. 2019 Sep 30. doi: 10.1272/jnms.JNMS.2020_87-104. [Epub ahead of print]

3.

Oleic acid is a potent inducer for lipid droplet accumulation through its esterification to glycerol by diacylglycerol acyltransferase in primary cortical astrocytes.

Nakajima S, Gotoh M, Fukasawa K, Murakami-Murofushi K, Kunugi H.

Brain Res. 2019 Sep 25;1725:146484. doi: 10.1016/j.brainres.2019.146484. [Epub ahead of print]

PMID:
31562840
4.

What Are Factors Contributing to Improvement of Overactive Bladder Symptoms after Alpha-1 Blocker Treatment in Patients with Both Storage and Voiding Symptoms?

Matsukawa Y, Majima T, Takai S, Funahashi Y, Kato M, Gotoh M.

Urol Int. 2019 Sep 25:1-5. doi: 10.1159/000502661. [Epub ahead of print]

PMID:
31554005
5.

Development and validation of grade-based prediction models for postoperative morbidity in gastric cancer resection using a Japanese web-based nationwide registry.

Haga Y, Miyata H, Tsuburaya A, Gotoh M, Yoshida K, Konno H, Seto Y, Fujiwara Y, Baba H.

Ann Gastroenterol Surg. 2019 Jun 20;3(5):544-551. doi: 10.1002/ags3.12269. eCollection 2019 Sep.

6.

Frequency and risk factors for venous thromboembolism after gastroenterological surgery based on the Japanese National Clinical Database (516 217 cases).

Hata T, Ikeda M, Miyata H, Nomura M, Gotoh M, Sakon M, Yamamoto K, Wakabayashi G, Seto Y, Mori M, Doki Y.

Ann Gastroenterol Surg. 2019 Jul 22;3(5):534-543. doi: 10.1002/ags3.12275. eCollection 2019 Sep.

7.

Clinical characteristics and useful signs to differentiate detrusor underactivity from bladder outlet obstruction in men with non-neurogenic lower urinary tract symptoms.

Matsukawa Y, Yoshida M, Yamaguchi O, Takai S, Majima T, Funahashi Y, Yono M, Sekido N, Gotoh M.

Int J Urol. 2019 Sep 21. doi: 10.1111/iju.14121. [Epub ahead of print]

PMID:
31542892
8.
9.

Allogeneic hematopoietic cell transplantation in patients with untreated acute myeloid leukemia: a KSGCT multicenter retrospective analysis.

Tachibana T, Ishizaki T, Takahashi S, Najima Y, Kimura SI, Sakaida E, Onizuka M, Mori T, Fujisawa S, Fujiwara SI, Saito T, Hagihara M, Aotsuka N, Gotoh M, Usuki K, Tsukada N, Kanda J, Kanamori H, Kanda Y, Okamoto S; Kanto Study Group for Cell Therapy (KSGCT).

Bone Marrow Transplant. 2019 Sep 19. doi: 10.1038/s41409-019-0689-8. [Epub ahead of print] No abstract available.

PMID:
31537900
10.

A case of bulky pseudohyperplastic prostatic adenocarcinoma.

Narita T, Kondo A, Maeda M, Funahashi Y, Tanaka K, Gotoh M.

Aktuelle Urol. 2019 Sep 4. doi: 10.1055/a-0978-6148. [Epub ahead of print]

PMID:
31486059
11.

A case of metastatic prostate cancer treated with metastasectomy.

Miyata Y, Funahashi Y, Yamamoto A, Sassa N, Matsukawa Y, Gotoh M.

Aktuelle Urol. 2019 Aug 26. doi: 10.1055/a-0943-3647. [Epub ahead of print]

PMID:
31450244
12.

Safety profile and immunological response of dual sublingual immunotherapy with house dust mite tablet and Japanese cedar pollen tablet.

Gotoh M, Okubo K, Yuta A, Ogawa Y, Nagakura H, Ueyama S, Ueyama T, Kawashima K, Yamamoto M, Fujieda S, Sakashita M, Sakamoto H, Iwasaki N, Mori E, Endo T, Ohta N, Kitazawa H, Okano M, Asako M, Takada M, Terada T, Inaka Y, Yonekura S, Matsuoka T, Kaneko S, Hata H, Hijikata N, Tanaka H, Masuyama K, Okamoto Y.

Allergol Int. 2019 Aug 14. pii: S1323-8930(19)30108-X. doi: 10.1016/j.alit.2019.07.007. [Epub ahead of print]

13.

2-Carba cyclic phosphatidic acid inhibits lipopolysaccharide-induced prostaglandin E2 production in a human macrophage cell line.

Shibaike Y, Gotoh M, Ogawa C, Nakajima S, Yoshikawa K, Kobayashi T, Murakami-Murofushi K.

Biochem Biophys Rep. 2019 Jul 19;19:100668. doi: 10.1016/j.bbrep.2019.100668. eCollection 2019 Sep.

14.

Surgical outcomes of gastroenterological surgery in Japan: Report of the National Clinical Database 2011-2017.

Hasegawa H, Takahashi A, Kakeji Y, Ueno H, Eguchi S, Endo I, Sasaki A, Takiguchi S, Takeuchi H, Hashimoto M, Horiguchi A, Masaki T, Marubashi S, Yoshida K, Konno H, Gotoh M, Miyata H, Seto Y.

Ann Gastroenterol Surg. 2019 May 20;3(4):426-450. doi: 10.1002/ags3.12258. eCollection 2019 Jul.

15.

Risk calculator for predicting postoperative pneumonia after gastroenterological surgery based on a national Japanese database.

Takesue Y, Miyata H, Gotoh M, Wakabayashi G, Konno H, Mori M, Kumamaru H, Ueda T, Nakajima K, Uchino M, Seto Y.

Ann Gastroenterol Surg. 2019 Apr 22;3(4):405-415. doi: 10.1002/ags3.12248. eCollection 2019 Jul.

16.

Surgical quality improvement programs in Japan and USA: Report from the collaborative projects between Japanese Society of Gastroenterological Surgery and American College of Surgeons National Surgical Quality Improvement Program.

Marubashi S, Liu JY, Miyata H, Cohen ME, Ko CY, Seto Y, Gotoh M.

Ann Gastroenterol Surg. 2019 Apr 22;3(4):343-351. doi: 10.1002/ags3.12250. eCollection 2019 Jul. Review.

17.

Comparison of the Uroflowmetry Parameter Results Between Transgender Males Undergoing Gender-Affirming Hormone Therapy and Age-Matched Cisgender Females: Preliminary Data.

Matsuo K, Ichihara K, Gotoh M, Masumori N.

Transgend Health. 2019 Jul 1;4(1):152-156. doi: 10.1089/trgh.2019.0025. eCollection 2019.

18.

[Mechanisms of allergen immunotherapy elucidated through integrated comparative analysis].

Kaminuma O, Gotoh M, Okubo K, Nakaya A, Hiroi T.

Nihon Yakurigaku Zasshi. 2019;154(1):23-27. doi: 10.1254/fpj.154.23. Review. Japanese.

PMID:
31308346
19.

Prophylactic Antiemetics for Haematological Malignancies: Prospective Nationwide Survey Subset Analysis in Japan.

Yoshida I, Tamura K, Miyamoto T, Shimokawa M, Takamatsu Y, Nanya Y, Matsumura I, Gotoh M, Igarashi T, Takahashi T, Aiba K, Kumagai K, Ishizawa K, Kurita N, Usui N, Hatake K.

In Vivo. 2019 Jul-Aug;33(4):1355-1362. doi: 10.21873/invivo.11611.

20.

Treatment duration-dependent efficacy of Japanese cedar pollen sublingual immunotherapy: Evaluation of a phase II/III trial over three pollen dispersal seasons.

Yonekura S, Gotoh M, Kaneko S, Kanazawa K, Takeuji Y, Okubo K, Okamoto Y.

Allergol Int. 2019 Oct;68(4):494-505. doi: 10.1016/j.alit.2019.05.002. Epub 2019 Jun 27.

21.

Sex differences in the safety of S-1 plus oxaliplatin and S-1 plus cisplatin for patients with metastatic gastric cancer.

Yamada Y, Koizumi W, Nishikawa K, Gotoh M, Fuse N, Sugimoto N, Nishina T, Amagai K, Chin K, Niwa Y, Tsuji A, Imamura H, Tsuda M, Yasui H, Fujii H, Yamaguchi K, Yasui H, Hironaka S, Shimada K, Hyodo I.

Cancer Sci. 2019 Sep;110(9):2875-2883. doi: 10.1111/cas.14117. Epub 2019 Jul 23.

22.

Impact of Previous, Simultaneous or Subsequent Bladder Cancer on Prognosis after Radical Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma.

Kuroiwa K, Inokuchi J, Nishiyama H, Kojima T, Kakehi Y, Sugimoto M, Tanigawa T, Fujimoto H, Gotoh M, Masumori N, Ogawa O, Eto M, Ohyama C, Yokomizo A, Matsuyama H, Ichikawa T, Mizusawa J, Eba J, Naito S; JCOG UOSG.

J Urol. 2019 Jun 28:101097JU0000000000000422. doi: 10.1097/JU.0000000000000422. [Epub ahead of print]

PMID:
31251717
23.

Pre-surgical sunitinib treatment enabling nephron-sparing surgery in a patient with renal cell carcinoma in a solitary kidney.

Tochigi K, Funahashi Y, Mori A, Matsukawa Y, Kato M, Gotoh M.

Nagoya J Med Sci. 2019 May;81(2):337-340. doi: 10.18999/nagjms.81.2.337.

24.

Prognostic impact of cytogenetic abnormalities in adult patients with Philadelphia chromosome-negative ALL who underwent an allogeneic transplant.

Shimizu H, Doki N, Kanamori H, Sakura T, Mori T, Machida S, Takahashi S, Ohwada C, Fujisawa S, Yano S, Hagihara M, Kanda Y, Onoda M, Gotoh M, Kako S, Taguchi J, Usuki K, Kawai N, Aotsuka N, Okamoto S; Kanto Study Group for Cell Therapy (KSGCT).

Bone Marrow Transplant. 2019 Jun 11. doi: 10.1038/s41409-019-0585-2. [Epub ahead of print]

PMID:
31186516
25.

Docetaxel-based chemotherapy combined with dexamethasone 1 mg daily oral administration for castration-resistant prostate cancer: Long-term outcomes.

Tanaka N, Nishimura K, Okajima E, Ina K, Ogawa O, Nagata H, Akakura K, Fujimoto K, Gotoh M, Teramukai S, Hirao Y.

Int J Urol. 2019 Aug;26(8):797-803. doi: 10.1111/iju.14009. Epub 2019 May 5.

PMID:
31055879
26.

Thrombospondin 1-mediated suppression of mast cell degranulation is involved in the efficacy of sublingual immunotherapy.

Kaminuma O, Kitamura N, Gotoh M, Shindo M, Watanabe N, Saeki M, Nishimura T, Mori A, Nemoto S, Tatsumi H, Okubo K, Hiroi T.

Allergol Int. 2019 Sep;68S:S9-S10. doi: 10.1016/j.alit.2019.03.007. Epub 2019 Apr 25. No abstract available.

27.

The influence of the presence of intraductal carcinoma of the prostate on the grade group system's prognostic performance.

Kato M, Hirakawa A, Kobayashi Y Ms, Yamamoto A, Ishida R, Sano T, Kimura T, Majima T, Ishida S, Funahashi Y, Sassa N, Fujita T, Matsukawa Y, Yamamoto T, Hattori R, Gotoh M, Tsuzuki T.

Prostate. 2019 Jul;79(10):1065-1070. doi: 10.1002/pros.23818. Epub 2019 Apr 26.

PMID:
31025722
28.

Current status of site-specific cancer registry system for the clinical researches: aiming for future contribution by the assessment of present medical care.

Hirata K, Imamura M, Fujiwara T, Fukui T, Furukawa T, Gotoh M, Hakamada K, Ishiguro M, Kakeji Y, Konno H, Miyata H, Mori M, Okita K, Sato M, Shibata A, Takemasa I, Unno M, Yokoi K, Nishidate T, Nishiyama M.

Int J Clin Oncol. 2019 Sep;24(9):1161-1168. doi: 10.1007/s10147-019-01434-w. Epub 2019 Apr 22.

PMID:
31011913
29.

Investigation of the relationship between bladder function and sarcopenia using pressure flow studies in elderly male patients.

Majima T, Funahashi Y, Matsukawa Y, Inoue S, Sassa N, Kato M, Yamamoto T, Gotoh M.

Neurourol Urodyn. 2019 Jun;38(5):1417-1422. doi: 10.1002/nau.24001. Epub 2019 Apr 15.

PMID:
30989706
30.

Significance of the board-certified surgeon systems and clinical practice guideline adherence to surgical treatment of esophageal cancer in Japan: a questionnaire survey of departments registered in the National Clinical Database.

Toh Y, Yamamoto H, Miyata H, Gotoh M, Watanabe M, Matsubara H, Kakeji Y, Seto Y.

Esophagus. 2019 Oct;16(4):362-370. doi: 10.1007/s10388-019-00672-1. Epub 2019 Apr 12.

31.

Structure-Based Design, Synthesis, and Biological Evaluation of Imidazo[4,5-b]pyridin-2-one-Based p38 MAP Kinase Inhibitors: Part 1.

Kaieda A, Takahashi M, Fukuda H, Okamoto R, Morimoto S, Gotoh M, Miyazaki T, Hori Y, Unno S, Kawamoto T, Tanaka T, Itono S, Takagi T, Sugimoto H, Okada K, Snell G, Bertsch R, Nguyen J, Sang BC, Miwatashi S.

ChemMedChem. 2019 May 17;14(10):1022-1030. doi: 10.1002/cmdc.201900129. Epub 2019 Apr 18.

PMID:
30945818
32.

Urodynamic analysis of the impact of diabetes mellitus on bladder function.

Majima T, Matsukawa Y, Funahashi Y, Takai S, Kato M, Yamamoto T, Gotoh M.

Int J Urol. 2019 Jun;26(6):618-622. doi: 10.1111/iju.13935. Epub 2019 Mar 18.

PMID:
30887604
33.

[GUIDE TO ALLERGEN IMMUNOTHERAPY IN JAPANESE CEDAR POLLINOSIS].

Gotoh M.

Arerugi. 2019;68(2):81-85. doi: 10.15036/arerugi.68.81. Japanese. No abstract available.

PMID:
30867364
34.

The development of the ICIQ-UAB: A patient reported outcome measure for underactive bladder.

Uren AD, Cotterill N, Harding C, Hillary C, Chapple C, Lasch K, Stroupe A, Deshpande C, Delbecque L, Van Koeveringe G, Oelke M, Belal M, Bosch R, Blok B, Nitti V, Gotoh M, Takei M, Crawford B, Klaver M, Bongaerts D, Hakimi Z, Kos T, Abrams P.

Neurourol Urodyn. 2019 Mar;38(3):996-1004. doi: 10.1002/nau.23947. Epub 2019 Feb 22.

PMID:
30801826
35.

Usefulness of Shoulder36 in rotator cuff tears: Comparison with Simple Shoulder Test.

Kawakami J, Gotoh M, Matsuura K, Shin K, Fujito I, Tanaka A, Matsunaga S, Imai T, Nagamatsu T, Karasuyama M, Ohota T, Madokoro K, Shiba N.

J Orthop Surg (Hong Kong). 2019 Jan-Apr;27(1):2309499018819060. doi: 10.1177/2309499018819060.

PMID:
30798742
36.

Comparison in the efficacy of fesoterodine or mirabegron add-on therapy to silodosin for patients with benign prostatic hyperplasia complicated by overactive bladder: A randomized, prospective trial using urodynamic studies.

Matsukawa Y, Takai S, Majima T, Funahashi Y, Sassa N, Kato M, Yamamoto T, Gotoh M.

Neurourol Urodyn. 2019 Mar;38(3):941-949. doi: 10.1002/nau.23935. Epub 2019 Feb 19.

PMID:
30779375
37.

Thoracoscopic rib resection and reconstruction of chest wall: Our clinical experience.

Ueda Y, Nakagawa T, Tomioka Y, Toyazaki T, Gotoh M.

Asian J Endosc Surg. 2019 Feb 7. doi: 10.1111/ases.12691. [Epub ahead of print]

PMID:
30734502
38.

"Real-time" risk models of postoperative morbidity and mortality for liver transplants.

Marubashi S, Ichihara N, Kakeji Y, Miyata H, Taketomi A, Egawa H, Takada Y, Umeshita K, Seto Y, Gotoh M.

Ann Gastroenterol Surg. 2018 Nov 2;3(1):75-95. doi: 10.1002/ags3.12217. eCollection 2019 Jan.

39.

Diagnostic Utility of UroVysion Combined With Conventional Urinary Cytology for Urothelial Carcinoma of the Upper Urinary Tract.

Sassa N, Iwata H, Kato M, Murase Y, Seko S, Nishikimi T, Hattori R, Gotoh M, Tsuzuki T.

Am J Clin Pathol. 2019 Apr 2;151(5):469-478. doi: 10.1093/ajcp/aqy170.

PMID:
30668617
40.

[A CASE WITH LATE RECURRENCE OF EXTRAGONADAL GERM CELL TUMOR].

Mori A, Funahashi Y, Inoue S, Takai S, Matsuo K, Hirabayashi T, Suzuki T, Ishida S, Fujita T, Sassa N, Matsukawa Y, Kato M, Yoshino Y, Yamamoto T, Tsuzuki T, Gotoh M.

Nihon Hinyokika Gakkai Zasshi. 2018;109(1):40-44. doi: 10.5980/jpnjurol.109.40. Japanese.

41.

Pre-treatment serum testosterone level can be a useful factor to predict the improvement in bladder outlet obstruction by tadalafil for male patients with lower urinary tract symptoms induced by benign prostatic obstruction.

Matsukawa Y, Kanada Y, Takai S, Inoue S, Majima T, Funahashi Y, Kato M, Yamamoto T, Gotoh M.

Aging Male. 2019 Jan 16:1-7. doi: 10.1080/13685538.2018.1563777. [Epub ahead of print]

PMID:
30651033
42.

Representative survey of frozen shoulder questionnaire responses from the Japan Shoulder Society: What are the appropriate diagnostic terms for primary idiopathic frozen shoulder, stiff shoulder or frozen shoulder?

Kobayashi T, Karasuno H, Sano H, Hamada J, Takase K, Tamai K, Kashiwagi K, Hayashida K, Gotoh M, Yamamoto N, Morihara T, Hata Y, Morisawa Y.

J Orthop Sci. 2019 Jul;24(4):631-635. doi: 10.1016/j.jos.2018.12.012. Epub 2019 Jan 11.

PMID:
30638969
43.

Effects of Estrogen-Deficient State on Rotator Cuff Healing.

Tanaka K, Kanazawa T, Gotoh M, Tanesue R, Nakamura H, Ohzono H, Okawa T, Shiba N.

Am J Sports Med. 2019 Feb;47(2):389-397. doi: 10.1177/0363546518815869. Epub 2019 Jan 9.

PMID:
30625277
44.

Treatment of male stress urinary incontinence using autologous adipose-derived regenerative cells: Long-term efficacy and safety.

Gotoh M, Yamamoto T, Shimizu S, Matsukawa Y, Kato M, Majima T, Takai S, Funahashi Y, Toriyama K.

Int J Urol. 2019 Mar;26(3):400-405. doi: 10.1111/iju.13886. Epub 2018 Dec 17.

PMID:
30557919
45.

Efficacy of novel β3 -adrenoreceptor agonist vibegron on nocturia in patients with overactive bladder: A post-hoc analysis of a randomized, double-blind, placebo-controlled phase 3 study.

Yoshida M, Takeda M, Gotoh M, Yokoyama O, Kakizaki H, Takahashi S, Masumori N, Nagai S, Hashimoto K, Minemura K.

Int J Urol. 2019 Mar;26(3):369-375. doi: 10.1111/iju.13877. Epub 2018 Dec 17.

PMID:
30557916
46.

Long-term safety and efficacy of antimuscarinic add-on therapy in patients with overactive bladder who had a suboptimal response to mirabegron monotherapy: A multicenter, randomized study in Japan (MILAI II study).

Yamaguchi O, Kakizaki H, Homma Y, Igawa Y, Takeda M, Nishizawa O, Gotoh M, Yoshida M, Yokoyama O, Seki N, Okitsu A, Hamada T, Kobayashi A, Kuroishi K.

Int J Urol. 2019 Mar;26(3):342-352. doi: 10.1111/iju.13868. Epub 2018 Dec 13.

PMID:
30548692
47.

Long-Term Efficacy and Dose-Finding Trial of Japanese Cedar Pollen Sublingual Immunotherapy Tablet.

Gotoh M, Yonekura S, Imai T, Kaneko S, Horikawa E, Konno A, Okamoto Y, Okubo K.

J Allergy Clin Immunol Pract. 2019 Apr;7(4):1287-1297.e8. doi: 10.1016/j.jaip.2018.11.044. Epub 2018 Dec 8.

PMID:
30537561
48.

Prognostic factors affecting clinical outcomes after arthroscopic rotator cuff repair: importance of functional recovery by 3 months after surgery.

Nakamura Y, Gotoh M, Mitsui Y, Nakamura H, Ohzono H, Okawa T, Shiba N.

J Orthop Surg Res. 2018 Dec 5;13(1):310. doi: 10.1186/s13018-018-1014-8.

49.

The effect of herpes simplex virus vector-mediated gene therapy of protein phosphatase 1α on bladder overactivity and nociception.

Majima T, Mori K, Kadekawa K, Takai S, Funahashi Y, Reinhart B, Goins WF, Gotoh M, Glorioso JC, Yoshimura N.

Neurourol Urodyn. 2019 Feb;38(2):582-590. doi: 10.1002/nau.23882. Epub 2018 Nov 29.

PMID:
30499116
50.

BIM deletion polymorphism accounts for lack of favorable outcome in Japanese females with follicular lymphoma.

Ito Y, Umezu T, Tadokoro K, Saito Y, Katagiri S, Suguro T, Asano M, Yoshizawa S, Akahane D, Tanaka Y, Fujimoto H, Okabe S, Gotoh M, Tauchi T, Kawana C, Ohyashiki JH, Nakamura N, Ohyashiki K.

Leuk Lymphoma. 2019 May;60(5):1283-1288. doi: 10.1080/10428194.2018.1529310. Epub 2018 Nov 27.

PMID:
30480474

Supplemental Content

Support Center